SUMITOMO CHEM INDIA Latest Share Price (SUMICHEM)
TODAY IN ONE LINE
SUMICHEM fell 2.7% on average volume, lagging Nifty's -0.4% move, hovering dangerously near its 52-week low.
With a market cap of ₹17,976.73 Cr., it trades at a P/E of 31.02. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SUMITOMO CHEM INDIA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 11.5% YoY
- ●High Capital EfficiencyROCE of 16.7% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 16.0%
- ●Healthy Operating MarginsOPM is structurally strong at 22.7%
- ●High Promoter HoldingPromoters hold 75.0% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest SUMITOMO CHEM INDIA News
What changed recently?
Recent events, corporate actions, and announcements.
SUMITOMO CHEM INDIA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SUMITOMO CHEM INDIA, framed against the sector median so the premium or discount is obvious at a glance.
SUMITOMO CHEM INDIA trades at a P/E of 31.02× and P/B of 5.30×, against the Chemicals sector median P/E of 40.24×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SUMITOMO CHEM INDIA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SUMITOMO CHEM INDIA — derived from the latest tape, not yesterday's close.
SUMITOMO CHEM INDIA last traded at ₹360.6 with an intraday range of ₹358.2–₹375.65 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹360.60| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 406.33 | +45.73 | +12.68% |
| R3 | 388.88 | +28.28 | +7.84% |
| R2 | 382.27 | +21.67 | +6.01% |
| R1 | 371.43 | +10.83 | +3.00% |
| PIVOT | 364.82 | 4.22 | 1.17% |
| CURRENT | 360.60 | — | — |
| S1 | 353.98 | -6.62 | -1.83% |
| S2 | 347.37 | -13.23 | -3.67% |
| S3 | 336.53 | -24.07 | -6.67% |
| S4 | 319.08 | -41.52 | -11.51% |
SUMICHEM is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹365.8–₹375.65
Trading Below opening range, showing Bearishness
SUMITOMO CHEM INDIA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SUMITOMO CHEM INDIA — consolidated or standalone — with margins, YoY growth and key ratios inline.
SUMITOMO CHEM INDIA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹17,976.73 Cr. and reported EPS of ₹4.30.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 3,238 | 3,238 ▲ 0.0% |
| Sales Growth YoY %Derived | 2.85% | 2.85% |
| Other Income | 147 | 147 ▲ 0.0% |
| Total Income | 3,385 | 3,385 ▲ 0.0% |
| 1,877 | 1,877 ▲ 0.0% | |
| Gross ProfitDerived | 1,361 | 1,361 ▲ 0.0% |
| Gross Margin %Derived | 42.03% | 42.03% |
| 690 | 690 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 671 | 671 ▲ 0.0% |
| OPM %Derived | 20.72% | 20.72% |
| 58 | 58 ▲ 0.0% | |
| Profit Before Tax (PBT) | 728 | 728 ▲ 0.0% |
| 185 | 185 ▲ 0.0% | |
| Effective Tax %Derived | 25.37% | 25.37% |
| Total Profit for Period | 543 | 543 ▲ 0.0% |
| Less: Non-controlling Interests | 0 | 0 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 543 | 543 ▲ 0.0% |
| Net Profit Margin %Derived | 16.77% | 16.77% |
| PAT Growth YoY %Derived | 7.41% | 7.41% |
| Earnings Per Share (EPS ₹) | 10.88 | 10.88 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 50 | 50 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 6 | 6 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 2,657 | 2,657 ▲ 0.0% |
| Material Cost % of RevenueDerived | 50.98% | 50.98% |
| Employee Cost % of RevenueDerived | 8.45% | 8.45% |
| Other Cost % of RevenueDerived | 12.85% | 12.85% |
| Interest Coverage (x)Derived | 77.28x | 77.28x |
| Period | Mar 2020 | Jul 2020 | Mar 2021 | May 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,425 | 2,425 ▲ 0.0% | 2,645 ▲ 9.1% | 2,645 ▲ 0.0% | 3,065 ▲ 15.9% | 3,065 ▲ 0.0% | 3,511 ▲ 14.6% | 3,511 ▲ 0.0% | 2,844 ▼ 19.0% | 2,844 ▲ 0.0% | 3,149 ▲ 10.7% | 3,149 ▲ 0.0% | 3,238 ▲ 2.9% | 3,238 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 9.08% | — | 15.87% | 15.87% | 14.57% | 14.57% | -19.00% | -19.00% | 10.71% | 10.71% | 2.85% | 2.85% | |
| Other Income | 11 | 11 ▲ 0.0% | 19 ▲ 73.4% | 19 ▲ 0.0% | 27 ▲ 44.3% | 27 ▲ 0.0% | 45 ▲ 67.4% | 45 ▲ 0.0% | 96 ▲ 113.3% | 96 ▲ 0.0% | 120 ▲ 25.5% | 120 ▲ 0.0% | 147 ▲ 22.2% | 147 ▲ 0.0% | |
| Total Income | 2,435 | 2,435 ▲ 0.0% | 2,663 ▲ 9.4% | 2,663 ▲ 0.0% | 3,091 ▲ 16.1% | 3,091 ▲ 0.0% | 3,556 ▲ 15.0% | 3,556 ▲ 0.0% | 2,940 ▼ 17.3% | 2,940 ▲ 0.0% | 3,269 ▲ 11.2% | 3,269 ▲ 0.0% | 3,385 ▲ 3.6% | 3,385 ▲ 0.0% | |
1,608 | 1,608 ▲ 0.0% | 1,655 ▲ 3.0% | 1,655 ▲ 0.0% | 1,908 ▲ 15.3% | 1,908 ▲ 0.0% | 2,271 ▲ 19.0% | 2,271 ▲ 0.0% | 1,775 ▼ 21.8% | 1,775 ▲ 0.0% | 1,859 ▲ 4.7% | 1,859 ▲ 0.0% | 1,877 ▲ 1.0% | 1,877 ▲ 0.0% | ||
| Gross ProfitDerived | 817 | 817 ▲ 0.0% | 990 ▲ 21.1% | 990 ▲ 0.0% | 1,157 ▲ 16.9% | 1,157 ▲ 0.0% | 1,240 ▲ 7.2% | 1,240 ▲ 0.0% | 1,069 ▼ 13.8% | 1,069 ▲ 0.0% | 1,290 ▲ 20.7% | 1,290 ▲ 0.0% | 1,361 ▲ 5.5% | 1,361 ▲ 0.0% | |
| Gross Margin %Derived | 33.70% | 33.70% | 37.41% | 37.41% | 37.74% | 37.74% | 35.33% | 35.33% | 37.58% | 37.58% | 40.96% | 40.96% | 42.03% | 42.03% | |
484 | 484 ▲ 0.0% | 503 ▲ 3.9% | 503 ▲ 0.0% | 557 ▲ 10.8% | 557 ▲ 0.0% | 574 ▲ 3.1% | 574 ▲ 0.0% | 594 ▲ 3.6% | 594 ▲ 0.0% | 658 ▲ 10.6% | 658 ▲ 0.0% | 690 ▲ 4.9% | 690 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 333 | 333 ▲ 0.0% | 487 ▲ 46.1% | 487 ▲ 0.0% | 600 ▲ 23.2% | 600 ▲ 0.0% | 667 ▲ 11.1% | 667 ▲ 0.0% | 475 ▼ 28.8% | 475 ▲ 0.0% | 632 ▲ 33.2% | 632 ▲ 0.0% | 671 ▲ 6.1% | 671 ▲ 0.0% | |
| OPM %Derived | 13.74% | 13.74% | 18.41% | 18.41% | 19.58% | 19.58% | 18.99% | 18.99% | 16.69% | 16.69% | 20.07% | 20.07% | 20.72% | 20.72% | |
16 | 16 ▲ 0.0% | 52 ▲ 234.3% | 52 ▲ 0.0% | 51 ▼ 2.2% | 51 ▲ 0.0% | 57 ▲ 12.3% | 57 ▲ 0.0% | 67 ▲ 17.5% | 67 ▲ 0.0% | 72 ▲ 6.9% | 72 ▲ 0.0% | 58 ▼ 19.5% | 58 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 267 | 267 ▲ 0.0% | 453 ▲ 70.1% | 453 ▲ 0.0% | 576 ▲ 27.0% | 576 ▲ 0.0% | 654 ▲ 13.6% | 654 ▲ 0.0% | 503 ▼ 23.1% | 503 ▲ 0.0% | 680 ▲ 35.2% | 680 ▲ 0.0% | 728 ▲ 7.0% | 728 ▲ 0.0% | |
62 | 62 ▲ 0.0% | 108 ▲ 74.5% | 108 ▲ 0.0% | 152 ▲ 41.1% | 152 ▲ 0.0% | 152 ▼ 0.1% | 152 ▲ 0.0% | 133 ▼ 12.3% | 133 ▲ 0.0% | 174 ▲ 30.5% | 174 ▲ 0.0% | 185 ▲ 6.2% | 185 ▲ 0.0% | ||
| Effective Tax %Derived | 23.20% | 23.20% | 23.80% | 23.80% | 26.43% | 26.43% | 23.23% | 23.23% | 26.48% | 26.48% | 25.55% | 25.55% | 25.37% | 25.37% | |
| Total Profit for Period | 205 | 205 ▲ 0.0% | 345 ▲ 68.7% | 345 ▲ 0.0% | 424 ▲ 22.6% | 424 ▲ 0.0% | 502 ▲ 18.6% | 502 ▲ 0.0% | 370 ▼ 26.4% | 370 ▲ 0.0% | 506 ▲ 37.0% | 506 ▲ 0.0% | 543 ▲ 7.2% | 543 ▲ 0.0% | |
| Less: Non-controlling Interests | — | — | — | — | -0 | -0 ▲ 0.0% | — ▲ 100.0% | — | 0 | 0 ▲ 0.0% | 1 ▲ 366.5% | 1 ▲ 0.0% | 0 ▼ 98.8% | 0 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 205 | 205 ▲ 0.0% | 345 ▲ 68.7% | 345 ▲ 0.0% | 424 ▲ 22.6% | 424 ▲ 0.0% | 502 ▲ 18.6% | 502 ▲ 0.0% | 370 ▼ 26.4% | 370 ▲ 0.0% | 505 ▲ 36.8% | 505 ▲ 0.0% | 543 ▲ 7.4% | 543 ▲ 0.0% | |
| Net Profit Margin %Derived | 8.44% | 8.44% | 13.06% | 13.06% | 13.82% | 13.82% | 14.30% | 14.30% | 12.99% | 12.99% | 16.06% | 16.06% | 16.77% | 16.77% | |
| PAT Growth YoY %Derived | — | — | 68.74% | — | 22.63% | 22.63% | 18.57% | 18.57% | -26.42% | -26.42% | 36.79% | 36.79% | 7.41% | 7.41% | |
| Earnings Per Share (EPS ₹) | 4.10 | 4.10 ▲ 0.0% | 6.92 ▲ 68.8% | 6.92 ▲ 0.0% | 8.49 ▲ 22.7% | 8.49 ▲ 0.0% | 10.06 ▲ 18.5% | 10.06 ▲ 0.0% | 7.40 ▼ 26.4% | 7.40 ▲ 0.0% | 10.13 ▲ 36.9% | 10.13 ▲ 0.0% | 10.88 ▲ 7.4% | 10.88 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 50 | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -5 | -5 ▲ 0.0% | 2 ▲ 131.3% | 2 ▲ 0.0% | 2 ▲ 49.2% | 2 ▲ 0.0% | 2 ▼ 4.5% | 2 ▲ 0.0% | -0 ▼ 117.1% | -0 ▲ 0.0% | -1 ▼ 152.4% | -1 ▲ 0.0% | 6 ▲ 672.7% | 6 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 2,169 | 2,169 ▲ 0.0% | 2,210 ▲ 1.9% | 2,210 ▲ 0.0% | 2,516 ▲ 13.8% | 2,516 ▲ 0.0% | 2,902 ▲ 15.3% | 2,902 ▲ 0.0% | 2,437 ▼ 16.0% | 2,437 ▲ 0.0% | 2,588 ▲ 6.2% | 2,588 ▲ 0.0% | 2,657 ▲ 2.7% | 2,657 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 53.08% | 53.08% | 59.16% | 59.16% | 60.30% | 60.30% | 52.88% | 52.88% | 49.47% | 49.47% | 50.57% | 50.57% | 50.98% | 50.98% | |
| Employee Cost % of RevenueDerived | 7.39% | 7.39% | 7.35% | 7.35% | 6.59% | 6.59% | 6.22% | 6.22% | 8.16% | 8.16% | 8.41% | 8.41% | 8.45% | 8.45% | |
| Other Cost % of RevenueDerived | 12.57% | 12.57% | 11.66% | 11.66% | 11.57% | 11.57% | 10.12% | 10.12% | 12.74% | 12.74% | 12.48% | 12.48% | 12.85% | 12.85% | |
| Interest Coverage (x)Derived | 53.00x | 53.00x | 79.26x | 79.26x | 90.01x | 90.01x | 113.96x | 113.96x | 80.75x | 80.75x | 96.59x | 96.59x | 77.28x | 77.28x |
SUMITOMO CHEM INDIA segment analysis : revenue and profit mix.
Disclosed business segments at SUMITOMO CHEM INDIA with their share of revenue and profit, switchable between consolidated and standalone reporting.
SUMITOMO CHEM INDIA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SUMITOMO CHEM INDIA.
Our AI distills the core fundamental drivers supporting SUMITOMO CHEM INDIA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 40 (~1.0× the sector multiple of 40.2) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.18%.
SUMITOMO CHEM INDIA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SUMITOMO CHEM INDIA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
SUMITOMO CHEM INDIA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SUMITOMO CHEM INDIA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SUMITOMO CHEM INDIA delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SUMITOMO CHEM INDIA over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SUMITOMO CHEM INDIA stood at 61.4% of traded volume, against a 20-day average of 50.8%.
SUMITOMO CHEM INDIA announcements: results, concalls, ratings, M&A.
Filings SUMITOMO CHEM INDIA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
SUMITOMO CHEM INDIA files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 80 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sumitomo Chemical India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Analysts/Institutional Investor Meet/Con. Call Updates
Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet
Investor decks & rating reports.
SUMITOMO CHEM INDIA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SUMITOMO CHEM INDIA has declared, sequenced by announce and record date.
SUMITOMO CHEM INDIA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About SUMITOMO CHEM INDIA: business, sector, key facts.
What SUMITOMO CHEM INDIA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SUMITOMO CHEM INDIA operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: SUMICHEM, BSE: 542920.
Sumitomo Chemical India Limited (SCIL) is a prominent player in the Indian and international markets for chemical products, primarily focusing on three core sectors: agriculture, public health, and animal nutrition. Its business model revolves around the manufacturing and distribution of a diverse range of chemical solutions aimed at enhancing agricultural yields, protecting public health, and improving animal welfare.
Within the agricultural sector, SCIL provides a comprehensive portfolio of crop protection products. This includes insecticides, which target harmful insects affecting crops; herbicides, designed to control unwanted weeds; fungicides, combating fungal diseases in plants; and miticides, for managing mite infestations. The company also offers plant growth regulators to optimize plant development and increase productivity. This breadth of offerings allows SCIL to cater to a wide range of agricultural needs and conditions.
In the public health arena, SCIL manufactures and sells household and public health insecticides, contributing to disease control and prevention through the effective management of disease-carrying insects and pests. This segment plays a vital role in maintaining public health standards and safety, particularly in regions where vector-borne diseases are prevalent. The company's products are designed to be effective while adhering to safety regulations and minimizing environmental impact.
Finally, SCIL's commitment extends to the animal nutrition sector, where it supplies products that contribute to improved animal health and productivity. The precise nature of these products isn't fully detailed in the source material, but their inclusion highlights SCIL's multifaceted approach to providing chemical solutions across various sectors. This diversified strategy reduces reliance on any single market and enhances overall business resilience.
SCIL's operations extend beyond the domestic Indian market through its export activities, demonstrating its ability to compete and succeed on a global scale. The company's history, dating back to its incorporation in 2000, showcases its sustained presence and growth within the chemical industry. As a subsidiary of the larger Sumitomo Chemical Company Limited, SCIL benefits from significant resources, expertise, and a strong international network, further strengthening its market position and future prospects.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ASTEC LIFESCIENCES (ASTEC) Share PricePeer
- BHAGIRADHA CHEM & INDS L (BHAGCHEM) Share PricePeer
- BHARAT RASAYAN (BHARATRAS) Share PricePeer
- DHANUKA AGRITECH (DHANUKA) Share PricePeer
- DHARMAJ CROP GUARD (DHARMAJ) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about SUMITOMO CHEM INDIA (SUMICHEM).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SUMITOMO CHEM INDIA (SUMICHEM)?
The current share price of SUMITOMO CHEM INDIA (SUMICHEM) is ₹360.60. Today, the stock has declined by ₹9.90 (2.67%), trading in a range of ₹358.20 to ₹375.65. The stock opened at ₹371.95 with a trading volume of 3,47,161 shares.
02Is SUMITOMO CHEM INDIA stock a good investment for long-term?
SUMITOMO CHEM INDIA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹17,976.73 Cr., P/E ratio of 31.02, ROE of 16%, and ROCE of 16.68%. The dividend yield stands at 0.36%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of SUMITOMO CHEM INDIA stock?
The 52-week high price of SUMITOMO CHEM INDIA (SUMICHEM) is ₹572.05, while the 52-week low is ₹362.60. Currently trading at ₹360.60, the stock is -0.55% above its 52-week low and 36.96% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy SUMITOMO CHEM INDIA stock at the current price?
Whether to buy SUMITOMO CHEM INDIA stock at ₹360.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 31.02 and P/B ratio of 5.3. Today's performance shows a loss of 2.67%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of SUMITOMO CHEM INDIA and when is the next dividend?
SUMITOMO CHEM INDIA offers a dividend yield of 0.36%, which means for every ₹100 invested at the current price of ₹360.60, you can expect to receive approximately ₹0.36 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of SUMITOMO CHEM INDIA?
SUMITOMO CHEM INDIA's key financial metrics include: P/E Ratio: 31.02, P/B Ratio: 5.3, ROE: 16%, ROCE: 16.68%, Dividend Yield: 0.36%, EPS: ₹4.30, Book Value: ₹67.99, and Debt-to-Equity: 0. The company's market cap stands at ₹17,976.73 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is SUMITOMO CHEM INDIA stock performing today in the market?
SUMITOMO CHEM INDIA stock opened at ₹371.95 and is currently trading at ₹360.60, showing a decline of ₹9.90 (2.67%). The intraday high is ₹375.65 and low is ₹358.20. The trading volume stands at 3,47,161 shares, indicating moderate market participation today.
08What is the P/E ratio of SUMITOMO CHEM INDIA and what does it indicate?
SUMITOMO CHEM INDIA has a Price-to-Earnings (P/E) ratio of 31.02, which means investors are willing to pay 31.02 for every ₹1 of earnings. With an EPS of ₹4.30, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about SUMITOMO CHEM INDIA (SUMICHEM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.